← Back to Search

Mobile App for Depression in Multiple Sclerosis (MS-CATCH Trial)

N/A

Recruiting

Led By Riley Bove, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-12 months, 0-6 months, 6-12 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if MS CATCH can improve the patient-doctor relationship and increase patient satisfaction.

Who is the study for?

This trial is for California residents aged 18-80 with Multiple Sclerosis, who can use a mobile app and have mild to moderate depression. They must be able to give consent and follow the study plan without being limited by cognitive or visual issues, and should not have bipolar disorder, schizophrenia, or schizoaffective disorder.

What is being tested?

The MS CATCH smartphone application is being tested to see if it improves patient care in those with Multiple Sclerosis and depression. It lets patients report mood symptoms regularly for their neurologist to monitor through their medical records.

What are the potential side effects?

Since this trial involves using a mobile application rather than medication, traditional side effects are not expected. However, participants may experience stress or discomfort from regular self-monitoring of depressive symptoms.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-12 months, 0-6 months, 6-12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-12 months, 0-6 months, 6-12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-12 months, 0-6 months, 6-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adoption (uptake) - Primary

Adoption (uptake) - Secondary

Comprehensive Mood Evaluation - Secondary

+4 more

Secondary study objectives

Adherence - Secondary

Engagement (Sustained use) - Exploratory

Engagement (Sustained use) - Exploratoy

+8 more

Other study objectives

Self-Efficacy - Exploratory

Trial retention - Exploratory

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Arm 2: 6 month "usual care", 6 month MS CATCH tool interventionExperimental Treatment1 Intervention

Participants in arm 2 will receive 6 months "usual care" followed by 6 months of MS CATCH tool intervention. These first 6 months will be used to assess the definition of "usual care".

Group II: Arm 1: 12 month MS CATCH tool interventionExperimental Treatment1 Intervention

Participants in arm 1 will receive 12 months of use of the MS CATCH tool. This will include in-visit interventions and monthly questionnaires.

Do I qualify?Apply below to find out